Nandrolone F 100 - Ice Pharmaceuticals

Organon’s Durabolin played a pioneering role in anabolic therapy starting in the late 1950s. Used widely across Europe and Latin America, it treated a range of conditions including cancer-related cachexia and osteoporosis. The compound delivered consistent anabolic effects with minimal water retention. Despite its clinical success, it required injections several times per week. Eventually, its use declined with the rise of longer-acting nandrolone decanoate, though it remains available in limited markets.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Nandrolone F 100 by Ice Pharmaceuticals, consult with your doctor or healthcare professional.